Xcorporeal Inc. (XCRP)

Overview

Xcorporeal, Inc., originally a medical device company founded in 2001 and based in Lake Forest, California, has shifted its operations toward liquidation and dissolution. This transition is governed by a plan adopted by the company's board of directors on February 4, 2010. In accordance with this plan, Xcorporeal has established the Xcorporeal, Inc. Liquidating Trust and transferred all company assets to this trust. The primary aim of forming the trust is to oversee the systematic liquidation and dissolution of the company, marking the end of its operational phase. Prior to this shift, Xcorporeal, Inc. specialized in developing extra-corporeal platform technology designed for use in medical devices aimed at replicating the functions of various human organs.

Products and Services

Before transitioning to liquidation, Xcorporeal, Inc. was engaged in the innovation of medical technology, specifically focusing on the development of extra-corporeal devices. The aim was to create products that could support or replace the functions of human organs. The products and services provided by Xcorporeal included:

• Extra-corporeal Platform Technology: This technology served as the foundation for Xcorporeal's development efforts. It was aimed at creating devices that could be used outside the body to replicate the functions of various organs. The primary goal was to improve patient outcomes in critical and chronic conditions by providing external support to failing organs or replacing their function temporarily or permanently.